TOMITA K.; SUGAI S.; KOBAYASHI T.; MURAKAMI T., CHEM. AND PHARM. BULL., 1979, 27 NO 10, 2398-2404
作者:TOMITA K.、 SUGAI S.、 KOBAYASHI T.、 MURAKAMI T.
DOI:——
日期:——
Heterocycle RMB39 Modulators
申请人:Recursion Pharmaceuticals, Inc.
公开号:US20240092770A1
公开(公告)日:2024-03-21
Provided herein are compounds that modulate RMB39 and methods of using the compounds in RMB39-associated disorders, such as cancer (e.g., renal cell carcinoma).